Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Nora Therapeutics
530 Lytton Avenue, 2nd floor
Palo Alto, CA 94301
Phone: 443-378-7236
http://noratherapeutics.com/

Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine. Nora's lead compound, NT100, is a novel treatment being studied to improve pregnancy success rates and outcomes for women who have undergone multiple unsuccessful in vitro fertilization (IVF) procedures. NT100 is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract. NT100's mechanism of action may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance.

Key Contact
Name
Jeffrey K. Tong
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
04/17/14 $18,000,000 Series B Novo A/S
Prospect Venture Partners
Rho Ventures
Vivo Ventures
undisclosed